FIGO/ICM Guidelines for Preventing Rhesus Disease: A Call to Action
Overview
Affiliations
The introduction of anti-Rh(D) immunoglobulin more than 50 years ago has resulted in only a 50% decrease in Rhesus disease globally owing to a low uptake of this prophylactic approach. The International Federation of Gynecology and Obstetrics, International Confederation of Midwives, and Worldwide Initiative for Rhesus Disease Eradication have reviewed current evidence regarding the utility of anti-Rh(D) immunoglobulin. Taking into account the effectiveness anti-Rh(D), the new guidelines propose adjusting the dose for different indications and prioritizing its administration by indication.
Geta T, Atinafu B, Kassa T BMJ Public Health. 2025; 2(1):e000422.
PMID: 40018202 PMC: 11812781. DOI: 10.1136/bmjph-2023-000422.
General anaesthesia for nonobstetric surgery during pregnancy: A narrative review.
Bleeser T, Vally J, Van de Velde M, Rex S, Devroe S Eur J Anaesthesiol Intensive Care. 2025; 1(2):e003.
PMID: 39916685 PMC: 11783665. DOI: 10.1097/EA9.0000000000000003.
Junior M, Sosa S, Fernandes M, do Carmo L, de Oliveira R, Kanevsky G BMC Pregnancy Childbirth. 2024; 24(1):830.
PMID: 39707247 PMC: 11660609. DOI: 10.1186/s12884-024-07044-3.
Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort.
Gilstrop Thompson M, Xu W, Moore B, Wang T, Sun N, Pewar H Obstet Gynecol. 2024; 145(2):211-216.
PMID: 39591628 PMC: 11731044. DOI: 10.1097/AOG.0000000000005794.
[Cell salvage in obstetrics-Background and practical implementation].
Kotlyar M, Neef V, Rumpf F, Meybohm P, Zacharowski K, Kranke P Anaesthesiologie. 2024; 73(12):843-851.
PMID: 39542885 PMC: 11615018. DOI: 10.1007/s00101-024-01479-1.